Ford is cutting production of the F-150 Lightning electric pickup after weaker-than-expected electric vehicle sales growth.

While EV sales are growing in the U.S., the pace is falling well short of the industry’s ambitious timetable and many consumers are turning to hybrid vehicles instead.

Ford said that about 1,400 workers will be impacted by the move to lower F-150 Lightning production, with the Rouge Electric Vehicle Center transitioning to one shift, effective April 1. Approximately 700 employees will transfer to Ford's Michigan assembly plant while other workers will be placed in roles at the Rouge Complex or other facilities in Southeast Michigan. Some employees are expected to take advantage of the Special Retirement Incentive Program agreed to in the 2023 Ford-UAW contract.

Ford said a few dozen employees could be impacted at component plants supporting F-150 Lightning production, depending on how many workers apply for the retirement program. The company said it would provide placements for impacted employees within Southeast Michigan.

Ford also said Friday that it's creating almost 900 new jobs and adding a third crew at its Michigan assembly plant to meet demand for the Bronco and Bronco Raptor and the all-new Ranger and Ranger Raptor.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More